Connect with us
Grifols is a publicly traded Catalan pharmaceutical company. The company's activity is focused on the research, development, manufacturing, and marketing of plasma-derived products (blood products), intravenous...
Beyond the growth in turnover, profitability follows the same positive trend, with a gross operating result (Ebitda) that exceeded €40 million in 2022, 5.2% more than...
ALA Diagnostics closed its first round of financing in 2021 for the development of the Em Kit, the first test for the early diagnosis of Multiple...
Spanish biotech companies maintain their leading position in the industrial sector in science with the highest percentage of researchers. The research workplaces Spain in the ninth position...
Andalusia aims to improve the daily service and the technological evolution of professionals and citizens. The line of operation services will include the necessary tasks to...
Inbentus was established during the pandemic with the development of a Covid-19 respirator and has managed to successfully develop the first high-performance medical respirators with turbine...
Ship2B launched its first investment vehicle in 2016, with €4.5 million, investing in 23 companies of which they have already divested from three companies. In 2020, the...
Gilead Sciences had $6.4 billion in revenue in the first quarter of 2023, a 4% year-over-year decrease from the same period a year earlier. The company...
The objective of this first round of investment is to complete the development of the platform through which the company will provide services, with special attention...
AAVantgarde has two proprietary platforms for AAV-based large gene delivery: one that takes advantage of DNA recombination, called dual hybrid, and one of protein trans-splicing, called...
 |
|
 |  |
 |
|